Resources from the same session
mCRPC definition and benefits of treatment
Presenter: Ravindran Kanesvaran
Session: ESMO Colloquium supported by Astellas - State of the art management of mCPRC
Resources:
Slides
Optimal first-line treatment in mCRPC after either chemo or ARI in mHSPC
Presenter: Cora Sternberg
Session: ESMO Colloquium supported by Astellas - State of the art management of mCPRC
Resources:
Slides
Changing treatment algorithms in mCRPC: Role of PARP inhibitors
Presenter: Arun Azad
Session: ESMO Colloquium supported by Astellas - State of the art management of mCPRC
Resources:
Slides
Immunotherapy in mCRPC management
Presenter: Arun Azad
Session: ESMO Colloquium supported by Astellas - State of the art management of mCPRC
Resources:
Slides